CEACAM5 and colorectal carcinoma: Elevated serum IGFBP-2 levels in CRC patients correlate with neoplastic changes and increased CEA concentrations, indicating potential for early diagnosis and monitoring, though its standalone sensitivity and specificity are limited [134].